Genpact (G) is back in focus after expanding its alliance with Google Cloud to build AI led finance solutions for CFOs, a move that closely follows its recent first quarter results and updated 2026 guidance.

Genpact’s share price has been under pressure despite these AI and guidance updates, with the stock down about 30% year to date and the 1 year total shareholder return also declining about 25%. This suggests sentiment is still cautious even as management highlights growth plans and expands its Google Cloud alliance.

If this AI partnership has you thinking about where else automation could reshape earnings, it might be a good time to scan a broader field of 62 profitable AI stocks that aren't just burning cash

With Genpact trading around US$32.12, carrying a value score of 5 and sitting at a discount to analyst targets and some intrinsic estimates, you have to ask: is this weakness an opportunity, or is the market already discounting future growth?

Most Popular Narrative: 32.7% Undervalued

With Genpact last closing at $32.12 against a narrative fair value of $47.73, the most followed view points to a sizeable valuation gap built on detailed earnings and cash flow expectations.

Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.

Curious what kind of revenue mix, profit margins and valuation multiple are baked into that fair value, all discounted at 7.91%? The full narrative lays out a detailed roadmap of growth, profitability and capital returns that underpins the $47.73 figure.

Result: Fair Value of $47.73 (UNDERVALUED)

However, this hinges on Advanced Technology Solutions fully offsetting slower core BPO growth, and on large, multi year AI contracts being signed and executed as planned.

Next Steps

If this mix of caution and optimism has you on the fence, take a closer look at the underlying data so you can move quickly and build your own view using the 4 key rewards.

Looking for more investment ideas?

If Genpact has sparked new questions about where to put your money to work, do not stop here, use data driven shortlists to widen your opportunity set.

• Target potential bargains by scanning companies that combine quality fundamentals with attractive valuations through the 51 high quality undervalued stocks.
• Prioritize resilience by checking out businesses with stronger balance sheets and healthier financial footing via the solid balance sheet and fundamentals stocks screener (46 results).
• Spot lesser known opportunities by reviewing a hand picked screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.